ROSEN, GLOBALLY RESPECTED INVESTOR COUNSEL, Encourages Boston Scientific Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action - BSX

Core Viewpoint - Rosen Law Firm is reminding investors who purchased Boston Scientific Corporation common stock between July 23, 2025, and February 3, 2026, of the May 4, 2026, deadline to become a lead plaintiff in a class action lawsuit [1]. Group 1: Class Action Details - Investors who bought Boston Scientific common stock during the specified period may be eligible for compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - A class action lawsuit has already been filed, and interested parties can join by contacting Rosen Law Firm [3][6]. - The lawsuit alleges that Boston Scientific made misleading statements about its U.S. Electrophysiology segment, leading to a net income miss and disappointing guidance for the first half of fiscal 2026 [5]. Group 2: Law Firm Credentials - Rosen Law Firm specializes in securities class actions and has a strong track record, including the largest securities class action settlement against a Chinese company [4]. - The firm has consistently ranked highly in securities class action settlements, recovering hundreds of millions of dollars for investors, including over $438 million in 2019 alone [4].